US stocks open the week like they closed last week: on a high note, amid news the US Food and Drug Administration (FDA) had authorized the use of a COVID-19 treatment.
About 30 minutes into the Monday trading session, the benchmark Dow Jones Industrial Average climbed 0.5 percent to 28,081.45.
The broad-based S&P 500 jumped 0.7% to 3,419.92, and the tech-rich Nasdaq Composite Index increased 0.8% to 11,400.51, remaining buoyant after more than 30 record closes in 2020.
The quiet days of late August often produce big swings in share prices, but Wall Street got a boost after the FDA on Sunday issued an “emergency use authorization” allowing doctors to administer plasma from people who have recovered from COVID-19 to treat new patients.
“Based on scientific evidence available, the FDA concluded this product may be effective in treating COVID-19 and that the known and potential benefits of the product outweigh the known and potential risks of the product in hospitalized COVID-19 patients,” the agency said in a statement.
— AFP
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this